FDA is Going to Restrict or Eliminate Compounding Hormones?

Dr Neale Heal with Dr. Neale

This will effect many nuBirds (nuHealth patients)!

The FDA has said it will consider restricting or even eliminating cBHT based on a faulty research study. This is an existential threat for the compounding industry, and potentially a nightmare for the millions of Americans who rely on cBHT therapy. It will require an ambitious, long-term, and nationwide effort to stop it.

The Alliance for Pharmacy Compounding, with your help, is stepping up to protect your business and your patients. They’re planning a three-year, multi-pronged campaign to focus not on statistics, but on the human face of compounded hormone therapy: the patients it helps.

Check out this proof-of-concept video for a feel of the campaign’s tone:

APC is planning a nationwide electronic, print, and video effort targeted at the people who can make a difference. Please pledge if you can: https://a4pc.org.

This is more than a contribution. It’s an investment in the future of compounding practices and the ability to provide patients with the compounded hormones they need.